Testing clot-busting drug on brain bleed blood samples
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation clinical trials.
This study collects blood samples from people with and without bleeding risk to test a clot-dissolving drug (tPA) outside the body. It aims to improve minimally invasive surgery for brain hemorrhages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are willing to give written permission to participate
- You are receiving regular outpatient medical care
- You either have no known bleeding risk OR you have a bleeding risk from blood thinners, a bleeding disorder, low platelets, or need clotting treatment
- You can provide an extra blood sample (about 2 tablespoons) during a routine visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation and the brain's protective barrier are affected after a hemorrhagic stroke. It uses special brain scans to see these changes, which might help guide future care.
This study tests a new disposable tube with a camera (endoscope) that doctors use to remove a blood clot from the brain after a bleeding stroke. It is designed for people who are stable enough for surgery and whose bleed is in a part of the brain that is reachable with this tool.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
This trial tests a clot-busting drug (rhTNK-tPA) to remove blood from the ventricles (fluid spaces deep in the brain) after a spontaneous brain bleed. It may help patients whose ventricles are blocked by a large clot, reducing pressure and improving recovery.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.